Our Science
Surface is developing antibodies that target key components of the Tumor Microenvironment
Latest News
Surface Oncology Announces Initiation of Phase I Clinical Trial of SRF373 / NZV930
Careers at Surface
Culture counts. Surface Oncology’s science isn’t the only thing that sets it apart.